Examiner Misapplies Statutory Prohibition against Enlarging Claim Scope in Reexamination
| October 28, 2010
Qualcomm won an important victory yesterday when the PTO Board of Appeals reversed the reexamination examiner’s rejection of most of the claims of U.S. Patent No. 5,778,338 – see Ex parte Qualcomm. The ‘338 patent claims an apparatus and method for compressing speech for transmission. Qualcomm sued both Nokia and Broadcom for infringement of the ‘338 patent and later settled.
What interests us in the case, however, is the Board’s treatment of the examiner’s rejection of claims 9 and 10 for enlarging the scope of the claims, in violation of 35 U.S.C. § 305.
Read More/続きを読む
When can the Patentee use the Reexamination Prosecution History for Arguing Claim Construction?
| October 28, 2010
Accused infringers in District Court and ITC litigation often rely upon remarks made in the prosecution history of reexamination proceedings to argue for favorable construction of the claims in dispute. But can a patentee rely upon its own remarks from the reexamination history? The answer – according to Judge Sean F. Cox of the Eastern District of Michigan – depends on whether the patentee’s remarks in the reexamination were made for the purpose of affecting the litigation.
This Tuesday in Dura Global v. Magna Donnelly, Judge Cox issued a Markman ruling construing patent claims that were the subject of pending reexamination proceedings. Dura had filed a complaint against Magna in 2007 accusing it of infringing two patents for power slidable rear windows in cars. Magna later requested reexamination of the two patents.
Read More/続きを読む
NVIDIA Attack on Rambus Patent Among Reexamination Requests Filed the Week of October 18th
| October 26, 2010
In their litigation/reexamination wars, Rambus and NVIDIA often look like two boxers trying to slug each other into submission. That was true last Wednesday. The same day that the PTO issued its Notice of Intent to issue a reexamination certificate, confirming the claims of Rambus’ U.S. Patent No. 6,715,020, NVIDIA requested another reexamination (Inter Partes Request No. 2 below). The ‘020 patent is just one of 17 patents that Rambus has accused NVIDIA of infringing in their case pending in the Central District of California. Five of those Rambus patents in litigation were the subject of a recently settled ITC investigation. The ‘020 patent is related to Rambus’ U.S. Patent No. 7,209,997, which is also part of the California litigation and the subject of two pending reexaminations. NVIDIA is now appealing the reexamination examiner’s decision to confirm the patentability of the ‘997 claims (95/000,471).
The following inter partes requests were filed:
(1) 95/001,471 (electronically filed) – U.S. Patent No. 6,426,600 owned by Lautzenhiser Technologies, LLC and entitled PROPORTIONAL ACTUATOR CONTROL OF APPARATUS. Filed October 19, 2010 by PG Drives Technology, Inc. The ‘600 patent is currently the subject of a litigation styled Lautzenhiser Technologies, LLC v. Sunrise Medical HHG, Inc. et al. (S.D. Ind., Case No. 4:07-cv-00084-TWP-WGH, filed June 18, 2007).
(2) 95/001,472 (electronically filed) – U.S. Patent No. 6,715,020 owned by Rambus Inc. and entitled SYNCHRONOUS INTEGRATED CIRCUIT DEVICE. Filed October 20, 2010 by NVIDIA Corporation. The ‘020 patent is currently the subject of a litigation styled Rambus Inc. v. NVIDIA Corporation (N.D. Cal., Case No. 3:08-cv-03343-SI, filed July 10, 2008).
Read More/続きを読む
Stay Pending Reexamination Denied, where Request was Ex Parte
| October 26, 2010
A recent trend in trial judges’ consideration of motions to stay litigation pending completion of reexamination at the PTO, has been for the judge to be suspicious of ex parte requests, as opposed to inter partes requests. Judge Stadtmueller of the Eastern District of Wisconsin expressed such suspicions last week, when he denied a stay motion filed by the accused infringer in Adaptor v. Sealing Systems, 09-cv-1070.
Adaptor filed a complaint in November 2009 seeking a declaratory judgment that Sealing Systems’ U.S. Patent No. 5,876,533 was invalid and not infringed. Sealing Systems counter-claimed, asserting infringement by Adaptor. In April 2010 Adaptor filed a request for ex parte reexamination of the ‘533 patent, and in May the PTO granted the request. Adaptor then moved to stay its own declaratory judgment action and Sealing Systems’ counter-claim, pending completion of the reexamination.
Read More/続きを読む
Requester Appeals PTO’s Refusal to Adopt Rejections, and Wins (Corrected Version)
| October 22, 2010
Much is made of the fact that the PTO grants the overwhelming majority of requests for reexamination and then adopts at least some of the rejections proposed in the request. So what do you do if the PTO does not adopt your rejections? In May 2009 NuVasive requested inter partes reexamination of Warsaw Orthopedic’s U.S. Patent No. 6,969,390 for a medical appliance, proposing ten distinct prior art rejections. When the examiner granted the request, but refused to adopt the proposed rejections, NuVasive appealed. Yesterday the Board reversed the refusal and remanded the case to the examiner, with instructions to adopt NuVasive’s first proposed rejection of claim 1 and to reconsider four other proposed rejections of certain dependent claims.
The ‘390 patent claims a “plating system” for application to the human spine, including a cervical plate and a bone screw. The primary reference relied upon by NuVasive discloses each of the claim limitations, except for certain structural features of the screw. A secondary reference, however, discloses a plating system with a screw having those structural features. In denying the request for reexamination, the examiner concluded that there would be no reason for one skilled in the art to replace the screw of the primary reference with the screw of the secondary reference.
Read More/続きを読む
Reexamination Request Against Taser Patent Among Those Filed Week of October 11th
| October 19, 2010
The clear stand-out among the reexamination requests filed last week was one against U.S. Patent No. 6,999,295, the patent for the famous Taser® stun gun, owned by Taser International. The preamble of one of the ‘295 claims euphemistically recites a “dual operating mode electronic disabling device for immobilizing a target.” Taser successfully sued Stinger Systems in Arizona for infringement of the ‘295 patent, culminating in an infringement judgment in August. Taser owns another patent, U.S. Patent No. 7,102,870, claim 3 of which has been held to be invalid as obvious over the prior art.
A request was also filed against Apple’s U.S. Patent No. 5,946,647 (Ex parte No. 10). As reported by our friend Gene Quinn in IPWatchdog, Apple has sued HTC and Exeda for infringement of the ‘647 patent, among many other patents.
The following inter partes requests were filed:
(1) 95/001,464 (electronically filed) – U.S. Patent No. 7,578,439 owned by e2Interactive, Inc. and entitled SYSTEM AND METHOD FOR AUTHORIZING STORED VALUE CARD TRANSACTIONS. Filed October 11, 2010 by Blackhawk Network, Inc. The ‘439 patent is currently the subject of a litigation styled e2Interactive, Inc. et al. v. Blackhawk Network, Inc. (W.D. Wis., Case No. 3:09-cv-00629-slc, filed Oct. 14, 2009).
(2) 95/001,465 (electronically filed) – U.S. Patent No. 7,317,173 owned by Alto-Shaam, Inc. and entitled OVEN INCLUDING SMOKING ASSEMBLY IN COMBINATION WITH ONE OR MORE ADDITIONAL FOOD PREPARATION ASSEMBLIES. Filed October 13, 2010 by Cleveland Range LLC. The ‘173 patent (along with the ‘668 patent – see below) is currently the subject of a litigation styled Alto-Shaam, Inc. v. The Manitowoc Company et al. (N.D. Tex., Case No. 7:09-cv-00018-O, filed Jan. 27, 2009).
Read More/続きを読む
Judge Acknowledges Shift of “Validity Issue” to PTO in Staying Court Case
| October 19, 2010
Judge Larry Alan Burns of the Southern District of California has stayed the case DJO v. VitalWear, pending completion by the PTO of reexaminations of the two patents-in-suit. He applied the traditional three-part test for considering such stays – the stage of the litigation, possible prejudice to the patentee, and potential for simplification of the issues. It was Judge Burns’ comments on the issue of simplification, however, that were noteworthy.
First, he found that no one “can predict which claims, if any, will be cancelled, which will be amended, and which will emerge unscathed.” Accordingly, any litigation of the patents now would “likely be duplicative” of the reexamination proceedings.
More significantly, Judge Burns held that the patentee’s assertions (1) that the prior art cited in the reexamination proceedings is cumulative over the art cited in the original prosecution and (2) that the accused products would infringe any narrowed claims, “are precisely the types of disputes that the PTO is better equipped to resolve” than a trial court (emphasis added).
Read More/続きを読む
PTO Board Reverses Rejection of Artemis Medical Claims
| October 18, 2010
The PTO’s Central Reexamination Unit (CRU) has been criticized recently for construing claims too broadly, according to the “broadest reasonable construction” standard. Justice was done, however, in the Board’s decision Friday, Ex parte Artemis Medical, reversing the examiner’s rejection of the claims of U.S. Patent No. 6,730,042.
The ‘042 patent claimed a “target tissue localization device” for marking a biopsy cavity. The claims included the limitation of a bioresorbable body “comprising polylactic acid and polyglycolic acid.”
The examiner construed the claim as covering not only embodiments in which the bioresorbable body has both polylactic acid and polyglycolic acid, but also embodiments in which bioresorbable body has only polylactic acid and embodiments in which it has only polyglycolic acid. The examiner justified this broad construction on correspondingly broad disclosure in the ‘042 specification that the bioresorbable body could be “one or more” members of a list of materials. The examiner then rejected the claims as being obvious over a prior art reference, as well as being obvious over a combination of prior art references.
Read More/続きを読む
CAFC Finds HFC Patent Valid because Honeywell was not “Another Inventor” under § 102(g)(2)
| October 15, 2010
This Wednesday the CAFC held in Solvay v. Honeywell that Honeywell’s activities in the United States did not constitute prior art under 35 U.S.C. § 102(g)(2) against Solvay’s U.S. Patent No. 6,730,817. The CAFC therefore reversed the trial court’s summary judgment that the patent was rendered invalid by Honeywell’s activities. Solvay’s ‘817 patent claims a method for making hydrofluorocarbons (HFCs) that are used in refrigeration and aerosol systems, as environmentally-friendly alternatives to chlorofluorocarbons (CFCs).
Paragraph (g) is the so-called “interference provision” of Section 102, but it also defines prior art that may be used in infringement actions, as in the present Solvay case. Section 102(g)(2) provides in relevant part that a person is entitled to a patent if “before such person’s invention thereof, the invention was made in this country by another inventor who had not abandoned, suppressed, or concealed it” (emphasis added). The issue for the CAFC was whether Honeywell was “another inventor,” i.e., had it invented the claimed process. The CAFC said no.
Thankfully, the facts were not in dispute.
Read More/続きを読む
Reexamination Request Against Honeywell’s HFC Patent Among Those Filed Week of October 4th
| October 13, 2010
Honeywell has obtained a number of patents in recent years for hydrofluorocarbon (HFC) patents. HFCs are environmentally friendly alternatives to the hydrochlorofluorocarbons for use in aerosols and refrigerants. Inter partes Request No. 2 below challenges Honeywell’s patent.
A request was also filed against Medicis’ patent (Ex parte Request No. 9) for foaming pad containing benzoyl peroxide, used to treat acne. The ‘355 patent is the subject of a contentious case in Arizona, filed earlier this year.
The following inter partes requests were filed:
(1) 95/001,463 (electronically filed) – U.S. Patent No. 7,023,969 owned by InfoNXX, Inc. and entitled COMMUNICATION ASSISTANCE SYSTEM AND METHOD. Filed October 7, 2010.
(2) 95/000,574 (paper filed) – U.S. Patent No. 7,524,805 owned by Honeywell International Inc. and entitled AZEOTROPE-LIKE COMPOSITIONS OF TETRAFLUOROPROPENE & HYDROFLUOROCARBONS. Filed October 5, 2010.
Read More/続きを読む